Inogen | INGN - Umsatzerlöse





Der Umsatz Veränderung Datum
Abbott USD 11.16B 300M 2026-03
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 141.2M 700K 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Chart Industries USD 884.8M 195.2M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
Inogen USD 74.93M 504K 2024-09
Insulet USD 761.7M 22.1M 2026-03
Masimo USD 403.6M 8.9M 2026-03
Medtronic USD 9B 39M 2026-01
Orthofix International USD 219.91M 14.28M 2025-12
Philips EUR 3.91B 1.19B 2026-03
ResMed USD 1.4B 0 2026-03
Steris USD 1.59B 90M 2026-03
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
X T L Biopharmaceuticals USD 289K 127K 2024-12
Zimmer Biomet Holdings USD 2.09B 150M 2026-03